Risk Stratification for Acute Coronary Syndrome by Means of Fragments/Partial Peptides of Provasopressin, Especially Copeptin or Neurophysin II

摘要

The invention relates to a method for risk stratification for acute coronary syndrome (ACS), in particular acute myocardial infarction (AMI) and angina pectoris (AP), wherein provasopressin (proAVP) or fragments and partial peptides thereof, in particular copeptin or neurophysin II, is determined by an in vitro diagnosis.